FDA Adverse Event Other Summary report: N

ON-Q SILVERSOAKER

MDR report key: 1418512 · Received July 15, 2009

Report

Report Number
2026095-2009-00172
Event Type
Other
Date Received
July 15, 2009
Date of Event
June 12, 2009
Report Date
June 16, 2009
Manufacturer
I-FLOW CORP.
Product Code
BSO
PMA / PMN Number
UNK
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NV, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

THE INFO CONTAINED HEREIN IS BASED ON THE INFO PROVIDED BY THE INITIAL REPORTER. THE SAMPLE HAS NOT BEEN RECEIVED, BUT WAS REPORTED TO BE AVAILABLE FOR EVAL AND INVESTIGATION. WITHOUT THE ACTUAL PRODUCT OR LOT NUMBER, A COMPLETE ANALYSIS CANNOT BE CONDUCTED. I-FLOW HAS PREPARED A TECHNICAL BULLETIN IN ORDER TO PREVENT OR DECREASE CATHETER BREAKS ENTITLED: "TIP FOR PREVENTING IN-SITU CATHETER BREAKAGE WITH THE ON-Q POST-OP PAIN RELIEF SYSTEM." (1303971, REV. B). ALSO, IN THE PT GUIDELINE INSERT, I-FLOW HAD PROVIDED CATHETER REMOVAL INSTRUCTIONS TO ENSURE SAFE REMOVAL (1305285, REV. C). IT IS WORTH NOTING THAT I-FLOW'S CATHETERS ARE MADE OF A NON-TOXIC, MEDICAL-GRADE MATERIAL THAT MEETS ISO (B) (4) TISSUE COMPATIBILITY GUIDELINES FOR IMPLANTATION OF UP TO 30-DAYS; COMPLICATIONS MAY ARISE IF A CATHETER (OR PORTION THEREOF) IS LEFT IN THE BODY FOR LONGER THAN THIS PERIOD OF TIME. IF ADD'L INFO THAT IS PERTINENT TO THIS EVENT BECOMES AVAILABLE, I-FLOW WILL SUBMIT A FOLLOW-UP REPORT.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE NURSE WAS REMOVING THE CATHETERS OF THE DUAL ON-Q PUMP FROM THE PT, WHEN THE SECOND CATHETER GAVE HER RESISTANCE AND SNAPPED OFF IN PT. APPROX 22CM WAS LEFT IN THE PT; HOWEVER, NO X-RAY OR SCANS HAD BEEN DONE AT THE TIME OF THE REPORT. NURSE HAS BOTH OF THE CATHETERS SAVED FOR RETURN. THE CATHETER SEGMENT REMAINS IN THE PT AND THE PT IS IN EXCELLENT CONDITION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ON-Q SILVERSOAKER CATHETER BSO I-FLOW CORP. PMO25-A UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Other